A new prognostic index to make short-term prognoses in MDS patients treated with azacitidine: A combination of p53 expression and cytogenetics-Reference-Cited by-同舟云学术

A new prognostic index to make short-term prognoses in MDS patients treated with azacitidine: A combination of p53 expression and cytogenetics

Published:2016-02 Issue: Volume:41 Page:21-26
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Nishiwaki Satoshi,Ito Masafumi,Watarai Rie,Okuno Shingo,Harada Yasuhiko,Yamamoto Satomi,Suzuki Kotaro,Kurahashi Shingo,Iwasaki Toshihiro,Sugiura Isamu

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference34 articles.

1. p53 protein and control of growth;Winchester;Nature,1983

2. Cell immortalization and transformation by the p53 gene;Lane;Nature,1984

3. New insights into p53 regulation and gene therapy for cancer;Zeimet;Biochem. Pharmacol.,2000

4. Expression of the p53 oncogene in acute myeloblastic leukemia;Smith;J. Exp. Med.,1986

5. TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities;Kaneko;Blood,1995

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidine;International Journal of Hematology;2022-03-11

2. Combined utility of CD177, P53, CD105 and c-kit immunohistochemical stains improves the detection of myelodysplastic syndrome;Annals of Diagnostic Pathology;2021-12

3. Predicting outcome in higher-risk myelodysplastic syndrome patients treated with azacitidine;Epigenomics;2021-07

4. TP53 mutated myeloid malignancies and their treatment strategy;Journal of Hematopoietic Cell Transplantation;2021

5. Relationship between p53 expression and prognosis of myelodysplastic syndrome treated with azacitidine;Journal of Hematopathology;2020-08-20